Amicogen Inc (092040) - Total Liabilities

Latest as of March 2026: ₩80.33 Billion KRW ≈ $54.44 Million USD

Based on the latest financial reports, Amicogen Inc (092040) has total liabilities worth ₩80.33 Billion KRW (≈ $54.44 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Amicogen Inc to track the company's year-over-year net asset growth rate.

Amicogen Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how Amicogen Inc's total liabilities have evolved over time, based on quarterly financial data. See Amicogen Inc (092040) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Amicogen Inc Competitors by Total Liabilities

The table below lists competitors of Amicogen Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Orient Paper & Industries Limited NSE:ORIENTPPR	India	Rs7.11 Billion
Entain PLC LSE:ENT	UK	GBX8.07 Billion
TechPrecision Corporation Common stock NASDAQ:TPCS	USA	$24.82 Million
Madusari Murni Indah Tbk PT JK:MOLI	Indonesia	Rp172.03 Billion
Defiance Silver Corp V:DEF	Canada	CA$720.25K
SMS Lifesciences India Limited NSE:SMSLIFE	India	Rs1.71 Billion
DKLS Industries Bhd KLSE:7528	Malaysia	RM85.66 Million
Exel Composites Oyj HE:EXL1V	Finland	€61.14 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Amicogen Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Amicogen Inc (092040) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.07	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.61	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.38	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Amicogen Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Amicogen Inc (2014–2025)

The table below shows the annual total liabilities of Amicogen Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩136.00 Billion ≈ $92.17 Million	-20.80%
2024-12-31	₩171.73 Billion ≈ $116.38 Million	-30.79%
2023-12-31	₩248.12 Billion ≈ $168.15 Million	-16.70%
2022-12-31	₩297.86 Billion ≈ $201.85 Million	+32.34%
2021-12-31	₩225.06 Billion ≈ $152.52 Million	+72.56%
2020-12-31	₩130.43 Billion ≈ $88.39 Million	+9.28%
2019-12-31	₩119.35 Billion ≈ $80.88 Million	+14.84%
2018-12-31	₩103.93 Billion ≈ $70.43 Million	+39.83%
2017-12-31	₩74.32 Billion ≈ $50.37 Million	+14.71%
2016-12-31	₩64.79 Billion ≈ $43.91 Million	-16.65%
2015-12-31	₩77.74 Billion ≈ $52.68 Million	+1688.10%
2014-12-31	₩4.35 Billion ≈ $2.95 Million	--

About Amicogen Inc

KQ:092040 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$42.13 Million

₩62.17 Billion KRW

Market Cap Rank

#22482 Global

#1401 in Korea

Share Price

₩1125.00

Change (1 day)

+5.63%

52-Week Range

₩1040.00 - ₩4220.00

All Time High

₩22094.22